BenevolentAI is an advanced technology company focused on accelerating the journey from data to medicines. Founded by Brent Gutekunst, Ivan Griffin, Ken Mulvany, and Michael Brennan in 2013, BenevolentAI is backed by investors that include Goldman Sachs, Lansdowne Partners, Lundbeck, Temasek Holdings, and Woodford Investment Management and is headquartered in London.
INDUSTRY:
Artificial Intelligence, Big Data, Biotechnology, Machine Learning, Neuroscience
FOUNDERS:
Brent Gutekunst, Ivan Griffin, Ken Mulvany, Michael Brennan
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
